Gregory M. Weinhoff, Chief Financial Officer at Centessa Pharmaceuticals plc (CNTA), sold 8,901 shares at $3.95 ($36K) on 2022-10-03, disclosed to the SEC on 2022-10-04.
Open-market sale of $36k CNTA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.07 | 4,000 | $16K | 45.7% |
| 2 | $3.95 | 4,901 | $19K | 54.3% |
| Total | $4.00 avg | 8,901 | $36K | 100% |
| Filing → |
| CNTA | SELL | 2025-07-25 | $156K | — | Filing → |
| CNTA | SELL | 2025-06-25 | $139K | — | Filing → |
| CNTA | SELL | 2025-05-27 | $128K | — | Filing → |